(R)-Pyrrolidin-2-ylmethanol
CAS : 68832-13-3
Ref. 3D-FP33861
5g | Arrêté | ||
10g | Arrêté | ||
25g | Arrêté | ||
50g | Arrêté | ||
100g | Arrêté |
Informations sur le produit
- (-)-2-Pyrrolidinemethanol
- (2-(<span class="text-smallcaps">D</span>)-Pyrrolidinyl)methanol
- (2R)-2-(hydroxymethyl)pyrrolidinium
- (2R)-2-Hydroxymethylpyrrolidine
- (2R)-2-Pyrrolidinemethanol
- (2R)-Pyrrolidin-2-ylmethanol
- (R)-(-)-2-(Hydroxymethyl)pyrrolidine
- (R)-(-)-2-(Hydroxymethyl)pyrrolidine (R)-(-)-2-Pyrrolidinemethanol
- (R)-(-)-2-Hydroxymethylpyrrolidine
- (R)-(-)-Prolinol
- Voir d'autres synonymes
- (R)-(-)-Pyrrolidine-2-methanol
- (R)-1-(Pyrrolidin-2-yl)methanol
- (R)-1-Pyrrolidin-2-ylmethanol
- (R)-2-Pyrrolidinemethanol
- (R)-Pyrrolidin-2-methanol
- (R)-pyrrolidin-2-ylmethanol
- 2-Pyrrolidinemethanol, (2R)-
- 2-Pyrrolidinemethanol, (R)-
- <span class="text-smallcaps">D</span>-Prolinol
(R)-Pyrrolidin-2-ylmethanol is a sodium salt of (R)-pyrrolidin-2-ylmethanol, which has been shown to have pharmacokinetic properties that are stereoselective. It has a hydroxyl group and an allyl ligand, and it is enantiopure. This compound has been shown to be active against herpes simplex virus, with possible structural analysis by hydrogen bonding and radiation. It also has the ability to bind to the kinase domain of the protein, inhibiting enzyme activity. The molecular modeling of this drug shows that it may be able to inhibit the phosphorylation of the tyrosine kinase domain by binding to the ATP site.